Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether 8 weeks treatment with mometasone furoate nasal spray (MFNS), twice daily, is safe and effective in treating adenoid hypertrophy in children.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00552032
Study type Interventional
Source Organon and Co
Contact
Status Completed
Phase Phase 3
Start date August 1, 2007
Completion date January 1, 2010

See also
  Status Clinical Trial Phase
Withdrawn NCT00553891 - Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED) Phase 4